Showing results (11-20 of 130) with videos related to
Sort By:
Pageof 13
Hypertension (Dallas, Tex. : 1979)|July 1, 1993
Comparative effects of three different potent renin inhibitors in primatesJ P Clozel, W FischliArzneimittel-Forschung|February 1, 1993
Discovery of remikiren as the first orally active renin inhibitorJ P Clozel, W FischliJournal of Cardiovascular Pharmacology|May 1, 1986
Cilazapril prevents hypertension in spontaneously hypertensive ratsF Hefti, W Fischli, M GeroldJournal of Receptor Research|January 1, 1984
Effects of temperature and allosteric modulators on [3H] nitrendipine binding: methods for detecting potential Ca2+ channel blockersM Holck, W Fischli, U HengartnerFEBS Letters|March 25, 1996
The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443M Clozel, V BreuAnnales D'Endocrinologie|May 3, 2000
[The pharmacology of endothelin and its antagonist bosentan]M Clozel, S RouxLife Sciences|January 1, 1993
BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionM Clozel, H WatanabeJournal of Hypertension|February 1, 1992
A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiationM Véniant, J P Clozel, W FischliThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1984
Opioid receptor selectivity of dynorphin gene productsI F James, W Fischli, A GoldsteinBritish Journal of Clinical Pharmacology|January 1, 1989
Effects of acute and chronic cilazapril treatment in spontaneously hypertensive ratsW Fischli, F Hefti, J P ClozelPageof 13